Meeting on the Mesa comes at pivotal time for cell and gene therapy industry
October 5, 2022 -- Stakeholders from around the cell and gene therapy sector will come together during the Alliance for Regenerative Medicine’s hybrid 2022 Meeting on the Mesa, October 11-13 in Carlsbad, CA, to discuss the opportunities and challenges facing the industry. Read More
FDA creates “Super Office” to manage growing cell and gene therapy workload
October 4, 2022 -- The U.S. Food and Drug Administration (FDA) has elevated and reorganized its Office of Tissues and Advanced Therapies to a “Super Office” within the Center of Biologics Research and Evaluation to meet its growing cell and gene therapy workload. Read More
Mixed bag so far in 2022 for cell and gene therapy sector: ARM report
October 3, 2022 -- So far, 2022 has been a mixed bag for the cell and gene therapy sector on the regulatory and investment fronts, according to a new report from the Alliance for Regenerative Medicine (ARM). Read More
Biotech licenses drug discovery platform from Harvard, Tufts to study complex CNS diseases
September 28, 2022 -- Unravel Biosciences has licensed a drug discovery platform from Harvard University and Tufts University to decode and model complex central nervous system (CNS) diseases. Read More
CRISPR edited rat embryos reveal cause of rare pediatric neurodegenerative disease
September 27, 2022 -- Using CRISPR gene editing technology on rat embryos, University of Wisconsin-Madison researchers have revealed the mutation that is responsible for progressive gait abnormalities and other symptoms in human infants and young children with a rare neurodegenerative disease. Read More
Gene editing possible for inherited retinal diseases
September 26, 2022 -- Precision genome editing agents can enable gene correction and disease rescue in inherited retinal diseases, according to University of California, Irvine researchers. Read More
Demand for viral vectors seen outpacing capacity growth despite investment surge
September 19, 2022 -- The growth in demand for viral vectors is outpacing a push to add capacity, leading to predictions that the current supply shortage will continue despite investment in the space. Read More
Federal funding of $2B to support biotechnology and biomanufacturing
September 14, 2022 -- The White House announced on Wednesday federal funding of more than $2 billion to advance President Joe Biden’s executive order intended to enable the U.S. to harness the full potential of biotechnology and biomanufacturing. Read More
New type of CAR T cells provide on-off switch to improve cell therapy safety, efficiency
September 12, 2022 -- Researchers at Boston University have created on and off switches for chimeric antigen receptor (CAR) T cells, enabling them to control the activity of therapies using an approved drug. Read More
Penn State-led team develops more efficient system for delivering CRISPR to stem cells
September 9, 2022 -- Modified mRNA (modRNA)-based CRISPR systems improve on the transfection and knockout efficiency of plasmid-based systems in human pluripotent stem cells (hPSCs), a Penn State-led team of interdisciplinary researchers has found. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
